Evidence map›Paper›PMID 41653498›Full record

ReviewMolecular pharmacology2026

Oligomerization of transmembrane adenylyl cyclase isoforms.

Sadikshya Aryal, John J G Tesmer, Carmen W Dessauer, Val J Watts

Abstract readReview
In one paragraph

Review in Molecular pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sadikshya AryalBorch Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana.
John J G TesmerBorch Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana; Department of Biological Sciences, Purdue University, West Lafayette, Indiana; Purdue Institutes for Integrative Neuroscience (PIIN), Drug Discovery (PIDD), Cancer Research (PICR), Inflammation, Immunology and Infectious Disease (PI4D), Purdue University, West Lafayette, Indiana.
Carmen W DessauerDepartment of Integrative Biology and Pharmacology, McGovern Medical School at the University of Texas Health Science Center, Houston, Texas.
Val J WattsBorch Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana; Purdue Institutes for Integrative Neuroscience (PIIN), Drug Discovery (PIDD), Cancer Research (PICR), Inflammation, Immunology and Infectious Disease (PI4D), Purdue University, West Lafayette, Indiana. Electronic address: wattsv@purdue.edu.

Funding

Structure, function, and inhibition of G protein-coupled receptor kinasesR01HL071818 · NHLBI · UNIVERSITY OF TEXAS AUSTIN · PI TESMER, JOHN · 2004 to 2023
$7.1M
Mechanisms of cAMP signaling that drive spontaneous activity in nociceptorsR01NS091759 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Carmen W. Dessauer, EDGAR T. WALTERS · 2015 to 2026
$4.9M
Regulation of the metastasis promoting chemokine receptor ACKR3 by GPCR kinases, Gβγ and arrestinsR01CA254402 · NCI · PURDUE UNIVERSITY · PI HANDEL, TRACY M, TESMER, JOHN · 2020 to 2024
$3.2M
KATP Channels as Downstream targets of adenylyl cyclases during opioid tolerance and withdrawalR01DA051876 · NIDA · UNIVERSITY OF MINNESOTA · PI KLEIN, AMANDA HELEN · 2021 to 2025
$2.9M
Regulation of Adenylyl Cyclase Signaling PathwaysR35GM145291 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Carmen W. Dessauer · 2022 to 2026
$2.1M
Pharmacological validation of adenylyl cyclase 1 as a drug target for chronic painR01NS119917 · NINDS · PURDUE UNIVERSITY · PI FLAHERTY, DANIEL PATRICK, WATTS, VAL J · 2021 to 2025
$2.0M
NCI NIH HHS R01 CA254402NIGMS NIH HHS R35 GM145291NIH HHS R01CA254402NIH HHS R01DA051876NIH HHS R01HL071818NIH HHS R01NS091759NIH HHS R01NS119917
6 · The paper itself

Abstract

Membrane-bound adenylyl cyclases (ACs) function as vital enzymes that convert external signals into intracellular responses through the second messenger cAMP. Traditionally viewed as monomers, ACs are now recognized to form oligomers, introducing new regulatory mechanisms. This minireview synthesizes emerging structural and biochemical evidence for AC oligomerization and explores its functional significance. Oligomerization plays a critical role in the localization of ACs by regulating retention in the endoplasmic reticulum, membrane targeting, and distribution within signaling microdomains. Functional data suggest that dimer/oligomer interfaces act as regulatory nodes, although isoform-specific differences in oligomer architecture and functional consequences remain poorly understood. Defining the mechanisms underlying these differences is a critical area for future investigation. Importantly, the structural variability of oligomer interfaces, relative to conserved catalytic domains, offers new therapeutic potential that may enable isoform-selective modulation of AC activity. By integrating past and current research, this review frames oligomerization as a fundamental, yet underexplored, determinant of cAMP signaling. Advancing our understanding of the assembly, regulation, and dynamics of AC oligomers may open new avenues for precise control of cAMP signaling in both physiological and pathological contexts. SIGNIFICANCE STATEMENT: Oligomerization of membrane adenylyl cyclases adds regulatory complexity to cAMP signaling by modulating catalytic activity, localization, and compartmentalization. Distinct homo- and hetero-oligomers may underlie isoform-specific functions and offer new therapeutic opportunities.

Indexed as

Adenylyl CyclasesCell MembraneProtein MultimerizationAnimalsCyclic AMPHumansIsoenzymesSignal TransductionAdenylyl CyclasesCyclic AMPIsoenzymescAMP signalingIsoform-specific regulationMembrane proteinsOligomerization

Identifiers

PMID41653498
PMCPMC13095467

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.